Cristina Quarta

2.5k total citations
16 papers, 374 citations indexed

About

Cristina Quarta is a scholar working on Molecular Biology, Epidemiology and Nephrology. According to data from OpenAlex, Cristina Quarta has authored 16 papers receiving a total of 374 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 8 papers in Epidemiology and 5 papers in Nephrology. Recurrent topics in Cristina Quarta's work include Amyloidosis: Diagnosis, Treatment, Outcomes (15 papers), Neuroendocrine Tumor Research Advances (6 papers) and Parathyroid Disorders and Treatments (5 papers). Cristina Quarta is often cited by papers focused on Amyloidosis: Diagnosis, Treatment, Outcomes (15 papers), Neuroendocrine Tumor Research Advances (6 papers) and Parathyroid Disorders and Treatments (5 papers). Cristina Quarta collaborates with scholars based in United Kingdom, United States and Italy. Cristina Quarta's co-authors include Ashutosh Wechalekar, Marianna Fontana, Helen J. Lachmann, Julian D. Gillmore, Philip N. Hawkins, Shameem Mahmood, Sajitha Sachchithanantham, Carol Whelan, Faye Sharpley and Richa Manwani and has published in prestigious journals such as Blood, European Heart Journal and Transplantation.

In The Last Decade

Cristina Quarta

14 papers receiving 368 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Cristina Quarta United Kingdom 7 305 113 88 79 78 16 374
Franco Bergesio Italy 10 268 0.9× 128 1.1× 86 1.0× 53 0.7× 39 0.5× 11 322
Roberta Mussinelli Italy 11 428 1.4× 171 1.5× 123 1.4× 128 1.6× 59 0.8× 22 500
S. Mahmood United Kingdom 5 243 0.8× 60 0.5× 71 0.8× 71 0.9× 62 0.8× 15 287
Ketna Patel United Kingdom 7 178 0.6× 62 0.5× 59 0.7× 41 0.5× 57 0.7× 18 261
Richa Manwani United Kingdom 11 362 1.2× 113 1.0× 22 0.3× 79 1.0× 114 1.5× 29 417
Constantinos Pamboukas Greece 6 252 0.8× 28 0.2× 39 0.4× 85 1.1× 91 1.2× 10 325
Sara Rosengren Sweden 7 290 1.0× 156 1.4× 118 1.3× 62 0.8× 6 0.1× 12 379
Oliver Cohen United Kingdom 9 261 0.9× 89 0.8× 17 0.2× 66 0.8× 82 1.1× 22 291
Karen Wells United States 4 332 1.1× 96 0.8× 4 0.0× 91 1.2× 106 1.4× 4 355
Sébastien Delbès France 3 165 0.5× 71 0.6× 9 0.1× 43 0.5× 25 0.3× 5 184

Countries citing papers authored by Cristina Quarta

Since Specialization
Citations

This map shows the geographic impact of Cristina Quarta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cristina Quarta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cristina Quarta more than expected).

Fields of papers citing papers by Cristina Quarta

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cristina Quarta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cristina Quarta. The network helps show where Cristina Quarta may publish in the future.

Co-authorship network of co-authors of Cristina Quarta

This figure shows the co-authorship network connecting the top 25 collaborators of Cristina Quarta. A scholar is included among the top collaborators of Cristina Quarta based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cristina Quarta. Cristina Quarta is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
2.
3.
Wechalekar, Ashutosh, Giovanni Palladini, Efstathios Kastritis, et al.. (2023). PB2150: CARDIAC AMYLOID REACHING FOR EXTENDED SURVIVAL (CARES) TRIALS: 2 PLACEBO-CONTROLLED, DOUBLE-BLIND, RANDOMIZED, PHASE 3 TRIALS ASSESSING CAEL-101 IN PATIENTS WITH MAYO STAGES IIIA/IIIB AL AMYLOIDOSIS. HemaSphere. 7(S3). e990776f–e990776f. 1 indexed citations
4.
Quarta, Cristina, Marianna Fontana, Thibaud Damy, et al.. (2022). Changing paradigm in the treatment of amyloidosis: From disease-modifying drugs to anti-fibril therapy. Frontiers in Cardiovascular Medicine. 9. 1073503–1073503. 13 indexed citations
5.
Wechalekar, Ashutosh, Marianna Fontana, Cristina Quarta, & Michaela Liedtke. (2022). AL Amyloidosis for Cardiologists. JACC CardioOncology. 4(4). 427–441. 35 indexed citations
6.
Baggiano, Andrea, Michele Boldrini, Ana Martinez–Naharro, et al.. (2019). Noncontrast Magnetic Resonance for the Diagnosis of Cardiac Amyloidosis. JACC. Cardiovascular imaging. 13(1). 69–80. 126 indexed citations
7.
Sharpley, Faye, Marianna Fontana, Janet A. Gilbertson, et al.. (2019). Amyloidosis Diagnosed in Solid Organ Transplant Recipients. Transplantation. 104(2). 415–420. 4 indexed citations
8.
Cohen, Oliver C., Faye Sharpley, Julian D. Gillmore, et al.. (2019). Ixazomib, lenalidomide and dexamethasone in relapsed AL amyloidosis – a first report. Clinical Lymphoma Myeloma & Leukemia. 19(10). e309–e309.
9.
Sharpley, Faye, Aviva Petrie, Shameem Mahmood, et al.. (2019). A 24‐year experience of autologous stem cell transplantation for light chain amyloidosis patients in the United Kingdom. British Journal of Haematology. 187(5). 642–652. 24 indexed citations
10.
Manwani, Richa, Oliver Cohen, Faye Sharpley, et al.. (2019). A prospective observational study of 915 patients with systemic AL amyloidosis treated with upfront bortezomib. Blood. 134(25). 2271–2280. 115 indexed citations
11.
Manwani, Richa, Sajitha Sachchithanantham, Shameem Mahmood, et al.. (2018). Treatment of IgM-associated immunoglobulin light-chain amyloidosis with rituximab-bendamustine. Blood. 132(7). 761–764. 23 indexed citations
12.
Martinez–Naharro, Ana, Thomas A. Treibel, Amna Abdel‐Gadir, et al.. (2017). 024 Spectrum and significance of CMR findings in cardiac transthyretin amyloidosis. Abstracts. A20–A21. 2 indexed citations
13.
Rosmini, Stefania, Elena Biagini, Constantinos O’Mahony, et al.. (2016). Relationship between aetiology and left ventricular systolic dysfunction in hypertrophic cardiomyopathy. Heart. 103(4). 300–306. 25 indexed citations
14.
Wechalekar, Ashutosh, Darren Foard, Carol Whelan, et al.. (2015). A Prospective Study of Treatment Outcomes in 179 Patients with Advanced Cardiac Stage STAGE IIIb Amyloidosis. Blood. 126(23). 5357–5357. 1 indexed citations
15.
Quarta, Cristina, Simone Longhi, Francesco Cappelli, et al.. (2013). Late onset cardiomyopathy due to transthyretin Ile68Leu mutation: a cardiogenic variant of familial amyloidosis potentially mimicking sarcomeric hypertrophic cardiomyopathy. European Heart Journal. 34(suppl 1). P2958–P2958. 1 indexed citations
16.
Ambrosini, Valentina, Cristina Quarta, Pier Luigi Zinzani, et al.. (2008). 18F-FDG small animal PET for early detection of human anaplastic large cells lymphoma xenograft in immunocompromised mice.. PubMed. 28(2A). 981–7. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Franco Bergesio Breakdown of academic impact, for papers by Roberta Mussinelli Breakdown of academic impact, for papers by S. Mahmood Breakdown of academic impact, for papers by Ketna Patel Breakdown of academic impact, for papers by Richa Manwani Breakdown of academic impact, for papers by Constantinos Pamboukas Breakdown of academic impact, for papers by Sara Rosengren Breakdown of academic impact, for papers by Oliver Cohen Breakdown of academic impact, for papers by Karen Wells Breakdown of academic impact, for papers by Sébastien Delbès
Rankless by CCL
2026